Recent studies suggest that ADB-Butinaca, a synthetic cannabinoid, may leave a identifiable residue in urinalysis, presenting a potential avenue for design of a accurate diagnostic approach. Nevertheless, extensive validation is critical to confirm its practical utility and rule out inaccurate fin